DIVA Laboratories Ltd
DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial case… Read more
Market Cap & Net Worth: DIVA Laboratories Ltd (4153)
DIVA Laboratories Ltd (TWO:4153) has a market capitalization of $60.47 Million (NT$2.00 Billion) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #24336 globally and #1474 in its home market, demonstrating a 1.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DIVA Laboratories Ltd's stock price NT$34.10 by its total outstanding shares 58668000 (58.67 Million).
DIVA Laboratories Ltd Market Cap History: 2015 to 2026
DIVA Laboratories Ltd's market capitalization history from 2015 to 2026. Data shows change from $109.61 Million to $60.47 Million (-7.10% CAGR).
DIVA Laboratories Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DIVA Laboratories Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
DIVA Laboratories Ltd's market cap is 0.08 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.72x
DIVA Laboratories Ltd's market cap is 0.72 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $58.24 Million | $857.00 Million | -$267.15 Million | 0.07x | N/A |
| 2018 | $56.87 Million | $650.13 Million | $52.15 Million | 0.09x | 1.09x |
| 2019 | $56.18 Million | $716.17 Million | $56.04 Million | 0.08x | 1.00x |
| 2020 | $41.89 Million | $736.92 Million | $17.42 Million | 0.06x | 2.40x |
| 2021 | $45.72 Million | $712.23 Million | $21.86 Million | 0.06x | 2.09x |
| 2022 | $70.19 Million | $949.20 Million | $49.66 Million | 0.07x | 1.41x |
| 2023 | $65.25 Million | $893.84 Million | $73.62 Million | 0.07x | 0.89x |
| 2024 | $67.82 Million | $862.32 Million | $93.66 Million | 0.08x | 0.72x |
Competitor Companies of 4153 by Market Capitalization
Companies near DIVA Laboratories Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to DIVA Laboratories Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
DIVA Laboratories Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, DIVA Laboratories Ltd's market cap moved from $109.61 Million to $ 60.47 Million, with a yearly change of -7.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$60.47 Million | -2.29% |
| 2025 | NT$61.88 Million | -8.76% |
| 2024 | NT$67.82 Million | +3.94% |
| 2023 | NT$65.25 Million | -7.03% |
| 2022 | NT$70.19 Million | +53.52% |
| 2021 | NT$45.72 Million | +9.15% |
| 2020 | NT$41.89 Million | -25.44% |
| 2019 | NT$56.18 Million | -1.22% |
| 2018 | NT$56.87 Million | -2.35% |
| 2017 | NT$58.24 Million | -10.00% |
| 2016 | NT$64.71 Million | -40.96% |
| 2015 | NT$109.61 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of DIVA Laboratories Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $60.47 Million USD |
| MoneyControl | $60.47 Million USD |
| MarketWatch | $60.47 Million USD |
| marketcap.company | $60.47 Million USD |
| Reuters | $60.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.